Last reviewed · How we verify
Induction Chemotherapy Triplet Therapy
Induction Chemotherapy Triplet Therapy is a Small molecule drug developed by Inova Health Care Services. It is currently in Phase 2 development.
At a glance
| Generic name | Induction Chemotherapy Triplet Therapy |
|---|---|
| Sponsor | Inova Health Care Services |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- VAG Versus Standard Chemotherapy With FLT3 Inhibitor in Adult Patients With FLT3-Mutated AML (PHASE3)
- Neoadjuvant FOLFOXIRI and Chemoradiotherapy Versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy Followed by Surgery or a Watch-and-Wait Approach in High Risk Locally Advanced Rectal Cancer (PHASE3)
- FLT3-ITD Targeted Therapy in Fit AML Patients (PHASE2, PHASE3)
- Venetoclax in Combination With Ivosidenib and Azacitidine for Newly Diagnosed IDH1-Mutated AML (PHASE1, PHASE2)
- Accelerated Neuromodulation to Alleviate Cognitive Deficits Due to Cancer Therapy (NA)
- Zeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL (PHASE2)
- Anti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type RAS and AREG/EREG High Status (PHASE4)
- A Study of NINLARO® in Chinese Adults With Multiple Myeloma
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Induction Chemotherapy Triplet Therapy CI brief — competitive landscape report
- Induction Chemotherapy Triplet Therapy updates RSS · CI watch RSS
- Inova Health Care Services portfolio CI
Frequently asked questions about Induction Chemotherapy Triplet Therapy
What is Induction Chemotherapy Triplet Therapy?
Induction Chemotherapy Triplet Therapy is a Small molecule drug developed by Inova Health Care Services.
Who makes Induction Chemotherapy Triplet Therapy?
Induction Chemotherapy Triplet Therapy is developed by Inova Health Care Services (see full Inova Health Care Services pipeline at /company/inova-health-care-services).
What development phase is Induction Chemotherapy Triplet Therapy in?
Induction Chemotherapy Triplet Therapy is in Phase 2.